NCT02920814

Brief Summary

The aims of this project are to determine the effectiveness of a time intensive form of Cognitive Behavioural Therapy (CBT) for Specific Phobia of Vomiting (SPOV). Current research shows that this brief format can be effective in other specific phobias e.g. insects and animals. However, to date limited research has been conducted on the effectiveness of time intensive forms of CBT for SPOV. A single case experimental design will be used to analyse specific and idiosyncratic outcome measures in 6-8 cases of SPOV, referred to the Centre for Anxiety Disorders and Trauma (CADAT) for treatment. Specifically, the project will explore the effectiveness of CBT delivered in a time-intensive format and imagery rescripting elements of the treatment. This initial study will provide important information about which elements of CBT are most effective at reducing targeted symptoms and whether symptom reduction can be achieved in a shorter number of sessions. It represents a crucial step before this format of CBT can be more rigorously evaluated and compared to other treatment approaches by Randomised Controlled Trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Apr 2016

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 30, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2018

Completed
Last Updated

December 5, 2018

Status Verified

April 1, 2016

Enrollment Period

2.4 years

First QC Date

September 29, 2016

Last Update Submit

December 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Specific Phobia of Vomiting Inventory (SPOVI)

    A 14-item self-report measure that focuses on cognitive processes, safety seeking and avoidance behaviours (Veale et al, 2013). The total score ranges from 0 to 56. The scale has a two-factor structure, with one factor of 7 items characterized by avoidance (e.g. "I have been trying to avoid or control any thoughts or images about vomiting") and a second factor of 7 items comprised of threat monitoring (e.g. "I have been focused on whether I feel ill and could vomit rather than on my surroundings"). Cronbach's α is .91.

    1 week

Secondary Outcomes (5)

  • Emetophobia Questionnaire

    1 week

  • Patient Health Questionnaire (PHQ-9)

    1 week

  • Generalised Anxiety Disorder (GAD7)

    1 week

  • Work and Social Adjustment Scale

    1 week

  • IAPT Employment Status Questions

    1 week

Study Arms (1)

Time Intensive CBT for SPOV

EXPERIMENTAL

Time intensive CBT for SPOV involving 6 weekly sessions and 2 intensive days of 4 hours each (over 8 weeks in total).

Other: Cognitive Behavioural Therapy

Interventions

Time intensive CBT over 8 weeks, including 6 weekly sessions and two intensive days of 4 hours each.

Time Intensive CBT for SPOV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or over with a diagnosis of SPOV as defined by DSM-5
  • The individual describes the SPOV as their main psychological problem
  • The individual is able to read materials written in English and answer written questions
  • Individuals must have capacity to provide written informed consent

You may not qualify if:

  • Involvement in active CBT (imagery rescripting and/or exposure) within 2 years or inactive CBT within 1 year previous to this study
  • Individuals with a diagnosis of any other mental health disorder that required treatment in its own right
  • Individuals currently taking anti-anxiolytic medication where the dose has not been stable over one month prior to entering the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Anxiety Disorders and Trauma

London, SE5 8AZ, United Kingdom

Location

MeSH Terms

Interventions

Cognitive Behavioral Therapy

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2016

First Posted

September 30, 2016

Study Start

April 1, 2016

Primary Completion

August 30, 2018

Study Completion

August 30, 2018

Last Updated

December 5, 2018

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations